 |
|
|
|
|
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Lardelli M. on PAPER: Schon EA. et al., 2012, This paper puts in perspective the very interesting results from Eric Schon's laboratory... 5 Apr 2013.
|
|
|
 |
|
|
Lardelli M. on PAPER: Ostergaard L. et al., 2013, A fascinating paper describing how capillary dysfunction would be expected to initially lead to... 16 Jan 2013.
|
|
|
|
|
|
Lardelli M. on PAPER: Area-Gomez E. et al., 2012, In future, this may be seen as an important paper that changed our ideas about the possible... 17 Sep 2012.
|
|
|
|
|
|
Lardelli M. on PAPER: Liao HK. et al., 2012, The paper by Liao et al. suggests a revision of our understanding of the biological role of the... 17 Mar 2012.
|
|
|
|
|
|
Lardelli M. on PAPER: Zetterberg H. et al., 2011, I agree with Kim Green. My lab recently showed that the upregulation of the genes required for... 4 Jan 2012.
|
|
|
|
|
|
Lardelli M. on NEWS: More Than APP—γ-Secretase, Metalloproteases Control Neurotransmission, The news article states that "γ-secretase appears primarily in endosomes," but the results of... 31 Aug 2011.
|
|
|
|
|
|
Lardelli M. on LIVE DISCUSSION: Reimagining Alzheimer's Disease—Time for Bright New Ideas?
, I think Prof. Herrup’s proposal is a very valuable contribution to the debate about mechanism. I... 4 May 2011.
|
|
|
|
|
|
Lardelli M. on NEWS: Editor’s Dozen: 13 Top AD Trends in 2010, The year 2010 was a very important one for presenilin research and involved a number of (in my... 5 Jan 2011.
|
|
|
|
|
|
Lardelli M. on SITE POLL: Are you in favor of ICAD going annual?, When discussing whether more frequent conferences are needed, we would do well to remember... 25 Nov 2008.
|
|
|
|
|
|
Lardelli M. on LIVE DISCUSSION: Do Somatic Mutations Generate Toxic Aβ Peptides in Sporadic Alzheimer Disease?, Why focus on APP as a target for somatic mutation when PSEN1 (and PSEN2) represents arguably a... 5 Feb 2008.
|
|
|
|
|
|
|
1 to 10 of 10 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
